PolyActiva Commences Clinical Trial of Biodegradable Ocular Implant for Glaucoma

Clinical Trial Begins For PolyActiva Biodegradable Glaucoma Implant. PolyActiva Pty Ltd, a clinical-stage Australian biotechnology company, has recently received USD$12million in venture capital to fund its Phase 1 Clinical Trial which will evaluate the safety and tolerability of its PA5108 ocular implant designed to biodegrade after the treatment period.

Pin It on Pinterest